SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: tom pope who wrote (31562)3/29/2005 10:23:10 PM
From: david nordic  Read Replies (1) | Respond to of 32384
 
Lgnd over the past several conferences durning the past year has reduce their projection from 600M to 400M in 2006. Now with 225M, that would indicate about 20% growth per year and with an expanded use on a current drug. Most likely Ontak or Avinza or some combo.

Like always when a stock is down everyone prays for buyout. Been there before.